ARCH Venture Management as of March 31, 2025
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 43.0 | $89M | 4.5M | 19.53 | |
| Maze Therapeatics (MAZE) | 22.0 | $45M | 4.1M | 11.01 | |
| Rapport Therapeutics (RAPP) | 18.2 | $38M | 3.7M | 10.07 | |
| Erasca (ERAS) | 7.3 | $15M | 11M | 1.37 | |
| Verve Therapeutics (VERV) | 4.4 | $9.1M | 2.0M | 4.54 | |
| Gossamer Bio (GOSS) | 4.3 | $8.8M | 8.1M | 1.09 | |
| Unity Biotechnology Com New | 0.5 | $1.0M | 1.0M | 1.04 | |
| Q32 Bio (QTTB) | 0.3 | $532k | 321k | 1.66 | |
| Cero Therapeutics Holdings Com New | 0.0 | $16k | 22k | 0.73 |
